- Novartis buys out cancer specialist AAA in $3.9 bn deal 01 November 2017
- Novartis begins human testing of new anti-malaria drug 21 August 2017
- Sun Pharma acquires Novartis' oncology brand Odomzo 22 December 2016
- Novartis to buy privately-held British biotech company Ziarco Group 16 December 2016
- Google and Novartis put off scheduled test of smart contact lens 22 November 2016
- Novartis to buy Selexys Pharmaceuticals for up to $665 mn 21 November 2016
- US FDA approves Novartis's biosimilar copy of Amgen's Enbrel 01 September 2016
- Novartis' S Korea executives charged with bribing doctors 13 August 2016
- Novartis to sell stake in Roche worth $13.8 bn 25 April 2016
- Sun Pharma in talks to buy Novartis' Japan portfolio 14 November 2015
- US claims $3.3 bn in Novartis kickback lawsuit 01 July 2015
- HC backs Novartis, bars Cipla from selling lung drug copy 10 January 2015
- Novartis-GSK business deal gets CCI nod 23 December 2014
- Dr Reddy's acquires quit-tobacco patch Habitrol from Novartis 19 December 2014
- Cipla wants Novartis's patents on respiratory drug revoked 30 October 2014
- CSL to acquire Novartis' influenza vaccine unit 27 October 2014
- Novartis fined Rs300 crore for overpricing painkiller Voveran 13 October 2014
- Novartis AG, GSK in $23-bn assets swap deal 22 April 2014
- May collaborate, not take over Roche: Novartis 03 March 2014
- Novartis acquires biotechnology company CoStim Pharmaceuticals 17 February 2014
- Chairman steps down even as Novartis posts profit rise 24 January 2013
- Cipla appoints Novartis' Subhanu Saxena as new CEO 22 November 2012
- Supreme Court asks Novartis to cut price of Glivec 13 September 2012
- Glivec is `special', Novartis argues in Supreme Court 11 September 2012
- Novartis restructures US operations, to cut 1,960 jobs 14 January 2012
- Novartis to eliminate 2,000 jobs, close two sites in Europe 25 October 2011
- Novartis plans $500 million investment in Russia 21 December 2010
- ImmunoGen to collaborate with Novartis on novel cancer treatment 12 October 2010
- Novartis aqnnounces novel antimalarial drug 06 September 2010
- Alcon directors deride Novartis offer as grossly inadequate 20 January 2010
- Novartis acquires Corthera, gets global rights to new heart drug 23 December 2009
- IBM, Novartis, Vodafone in novel venture to combat malaria in Africa 15 December 2009
- Novartis moves Supreme Court on Glivec patent 29 August 2009
- Novartis's open offer for Indian arm to begin on 14 May 27 March 2009
- Novartis makes open offer for 39 per cent in Indian arm 25 March 2009
- Unicef, Novartis among Mudra's new acounts 09 December 2008
- Novartis plans to cut 22,00 jobs worldwide 13 December 2007
- US FDA declares Novartis painkiller Prexige is ''not approvable'' 28 September 2007
- Switzerland not to take Novartis case before WTO 08 August 2007
- Chennai court rejects Novartis patent challenge 06 August 2007
- Government warns Novartis of compulsory licensing 10 April 2007
- India court reserves order in Novartis patent case 05 April 2007
- Novartis slumps after pulling Zelnorm 31 March 2007
- Novartis launches development centre in Mumbai 28 April 2004
- Novartis discontinues development of Dr Reddy’s compound 24 January 2003
- Novartis acquires global rights for Torrent’s AGE compound 07 November 2002
- Novartis sale of property to Kingston through 09 September 2002
- Glaxo SmithKline to sue Novartis, Ranbaxy 23 August 2002
- Novartis goes on with Dr Reddys work 26 December 2001
- Novartis to distribute cancer drug free to needy 11 May 2001
- Novartis'' blockbuster drug for leukemia 27 January 2001
